Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2009. Upgrade now.
Date Value
June 30, 2024 160.32M
March 31, 2024 201.97M
December 31, 2023 213.42M
September 30, 2023 197.56M
June 30, 2023 192.37M
March 31, 2023 184.78M
December 31, 2022 207.34M
September 30, 2022 188.70M
June 30, 2022 189.96M
March 31, 2022 189.67M
December 31, 2021 191.92M
September 30, 2021 183.31M
June 30, 2021 188.39M
March 31, 2021 206.25M
December 31, 2020 205.16M
September 30, 2020 181.74M
June 30, 2020 171.83M
March 31, 2020 147.61M
December 31, 2019 74.35M
September 30, 2019 68.89M
June 30, 2019 72.64M
March 31, 2019 73.29M
December 31, 2018 91.87M
September 30, 2018 82.53M
June 30, 2018 75.78M
Date Value
March 31, 2018 72.07M
December 31, 2017 70.37M
September 30, 2017 45.08M
June 30, 2017 28.60M
March 31, 2017 29.24M
December 31, 2016 33.54M
September 30, 2016 18.81M
June 30, 2016 23.82M
March 31, 2016 31.17M
December 31, 2015 34.60M
September 30, 2015 39.22M
June 30, 2015 27.79M
March 31, 2015 32.62M
December 31, 2014 41.57M
September 30, 2014 29.99M
June 30, 2014 35.82M
March 31, 2014 25.58M
December 31, 2013 23.43M
September 30, 2013 17.14M
June 30, 2013 16.98M
March 31, 2013 23.18M
December 31, 2012 6.974M
September 30, 2012 1.886M
March 31, 2012 10.53M
December 31, 2011 4.895M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

68.89M
Minimum
Sep 2019
213.42M
Maximum
Dec 2023
177.28M
Average
189.19M
Median

Cash and Short Term Investments (Quarterly) Benchmarks

uniQure NV 524.43M
ProQR Therapeutics NV 103.07M
Merus NV 787.42M
argenx SE 3.102B
Pharvaris NV 368.28M